ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2023

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 56 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 5,068,233$3,635,9507.58%
BML Capital Management, LLC 7,067,179$5,069,9944.38%
Sonic GP LLC 2,000,000$1,434,8001.10%
COMMODORE CAPITAL LP 5,000,000$3,587,0000.55%
CM Management, LLC 375,000$2690.32%
AIGH Capital Management LLC 1,200,000$860,8800.32%
Newtyn Management, LLC 1,528,400$1,096,4740.22%
Monaco Asset Management SAM 659,575$473,1790.14%
Worth Venture Partners, LLC 298,560$214,1870.10%
GSA CAPITAL PARTNERS LLP 879,684$6310.06%
Quinn Opportunity Partners LLC 398,298$285,7390.03%
Marquette Asset Management, LLC 121,393$87,0880.02%
Lipe & Dalton 15,000$110.01%
OCCUDO QUANTITATIVE STRATEGIES LP 52,560$37,7070.00%
Assenagon Asset Management S.A. 840,651$603,0830.00%
CANTOR FITZGERALD, L. P. 142,838$102,4720.00%
Virtu Financial LLC 14,498$100.00%
Renaissance Technologies 1,136,741$8150.00%
Connor, Clark & Lunn Investment Management Ltd. 149,856$107,5070.00%
TWO SIGMA INVESTMENTS, LP 621,122$445,5930.00%
External links

This page lists ADVERUM BIOTECHNOLOGIES INC's shareholders in Q1 2023. To view ADVERUM BIOTECHNOLOGIES INC's shareholder history, click here.